MG 013
Alternative Names: MG-013Latest Information Update: 07 Jun 2022
At a glance
- Originator Shanghai Mabgeek Biotech
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical IgA nephropathy
Most Recent Events
- 25 May 2022 Preclinical trials in IgA Nephropathy in China (unspecified route)(Shanghai Mabgeek Biotechnology pipeline, May 2022)